Hook / Thesis
monday.com is no longer just a visual work OS chasing SMB adoption — it is morphing into an enterprise-anchored, AI-monetizing platform. Q3 results surprised to the upside with $377.5M in revenue and $2.14 EPS, and management disclosed $36M of AI ARR and faster growth in large accounts. The market is punishing the stock after a sharp correction from the $164 52-week high; today the shares trade at $76.95. That disconnect creates a trade opportunity: if enterprise penetration and AI monetization continue to scale, the stock should re-rate from its current multiples.
Why the market should care
monday.com sells a cloud-based visual work operating system of modular blocks that teams use to build workflows and integrate business tools. Its value proposition is clear: simplify workflow automation and surface AI-enhanced productivity inside the same platform customers already use. The reason investors should care is two-fold: 1) enterprise accounts are growing faster and carry much higher ARR per account, and 2) early-stage AI monetization is meaningful enough to move revenue and margin trajectories if it continues to scale.
What the last quarter showed
On 11/11/2026 management reported results that matter for a re-rating. Revenue was $377.5M and EPS was $2.14, both beats. Management disclosed $36M in AI ARR and noted enterprise accounts above $100k ARR grew 37%. They also flagged nearly $100M in annualized cost savings from a recent restructuring. Those are tangible data points: AI is not a theoretical pipeline item — it is generating ARR; enterprise customers are expanding; and cost actions are structurally improving margins.
Valuation framing
Today shares trade at $76.95 and the company carries a market capitalization of roughly $3.25B. The dataset shows a trailing P/E of ~26.7x; other market commentary in recent coverage points to a forward P/E near 17x, implying some expectation of margin expansion. Compare that to the stock's 52-week range: a high of $164.49 (12/08/2025) and a low of $57.50 (04/10/2026). The sell-off has pushed the multiple into a range where reasonable top-line stabilization plus successful AI monetization could justify a higher multiple again. In plain terms: the market is pricing in either permanent demand deterioration or execution failure. If neither happens, multiple expansion is achievable.
Technicals and positioning
Technically, the stock is resting below its short- and medium-term moving averages (10-, 20-, 50-day SMAs hover around $87-$93). Momentum indicators show bearish MACD (-2.956 vs. signal -0.161) and an RSI of 34.16, indicating the shares are closer to oversold than overbought. Short interest has been elevated; the 10/30 settlement reported ~5.52M shares short with days-to-cover around 5.26. Short-volume spikes around the earnings window were significant (for example, on 11/09/2026 short volume represented ~71% of total volume). That setup creates asymmetric upside if fundamentals improve and the shorts cover.
Trade plan (actionable)
We recommend a tactical long with the following parameters. These are exact prices — no ranges:
| Entry | Stop | Target | Horizon |
|---|---|---|---|
| $76.95 | $65.00 | $110.00 | Long term (180 trading days) |
Why this plan? Entry at $76.95 gives direct exposure at the current market level where downside is already partly reflected in the stock’s 52-week low. A stop at $65.00 limits downside to the high-single-digit percentage band relative to today’s price and sits below the recent $57.50 low buffer zone and short-term support areas. The $110 target assumes a successful cadence: continued enterprise seat expansion, AI ARR growth that starts to show in forward guidance, and margin stabilization driven by the ~$100M annualized cost savings program. That target equates to a roughly 43% upside from entry and would be consistent with a modest multiple expansion back toward the lower end of the stock's historical valuation when growth re-accelerates.
Timeframe rationale
We expect the trade to play out over a long-term window (180 trading days) because management has guided that stabilization and the transformation to an AI-first platform will take several quarters into 2027. That timeline gives enough runway for enterprise deal cycles to convert, for AI products to add ARR meaningfully to recurring revenue, and for investors to re-price the shares as guidance and retention metrics improve.
Catalysts to watch
- Quarterly ARR disclosures showing sequential growth in AI ARR beyond the $36M reported on 11/11/2026.
- Continued acceleration in accounts >$100k ARR (the 37% increase is the early sign investors will be watching).
- Positive guidance or commentary on NDR/retention stabilizing as the platform becomes AI-first.
- Evidence that the near-$100M annualized cost savings are being realized and flowing to margin improvement.
- Partnerships or go-to-market wins with large enterprise customers that validate the AI use case at scale.
Counterarguments and alternative outcomes
A plausible counterargument is that AI ARR is still nascent and will prove sticky in headline presentation but immaterial in profit contribution for several more quarters. Management already guided slowing revenue growth to ~14% for Q4 2026, and longer enterprise sales cycles or SMB weakness could persist into 2027. If retention weakens (NDR pressure) or AI monetization stalls, the multiple could compress further and the stock would likely drift toward the lower end of its 52-week range. In short, the thesis depends on execution — the market will sharply discount that if the signals slip.
Risks (balanced)
- Execution risk: Turning AI prototypes into high-margin, recurring revenue is hard. If AI ARR growth slows below current momentum the re-rating stalls.
- Demand mix risk: The company has reported continued SMB weakness; if enterprise expansion does not offset SMB contraction the top line and NDR could underperform.
- Longer sales cycles: Management has flagged elongated enterprise cycles; delayed deals would push material upside beyond our 180 trading day horizon.
- Competitive pressure: Large incumbents and AI-native vendors could pressure pricing and customer acquisition economics.
- Market sentiment / short squeezes: Elevated short interest creates volatility both ways. A sustained risk-off in software names could keep the stock depressed even on good company news.
What would change our view
We would upgrade conviction and add to the position if: 1) AI ARR shows continued sequential doubling with clear gross margin contribution disclosed, 2) enterprise accounts >$100k ARR maintain double-digit growth quarter after quarter, and 3) management demonstrates concrete NDR improvement and delivers on the $100M cost-savings plan such that forward margins materially expand. Conversely, we would cut exposure or reverse the trade if guidance deteriorates further (revenue growth falling below low-teens sustainably), NDR weakens meaningfully, or enterprise bookings roll over.
Quick practical checklist for traders
Before entering at $76.95 make sure the next quarterly commentaries include: (a) AI ARR continuing its sequential growth trend, (b) at least a partial stabilization or improvement in NDR, and (c) no worsening in enterprise sales cadence commentary. If those boxes are ticked, the probability of a re-rate increases materially.
Bottom line: monday.com sits at an actionable valuation with concrete AI monetization and enterprise expansion evidence. This trade is a bet on execution — not on hype — and should be sized accordingly with the $65 stop guarding against the most likely downside scenarios while leaving room for the business to demonstrate the next leg of growth.